COLLEEN ANDRIJIW: Open Payments
NPI 1104916923 · GREELEY, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,459 in 56 payments from 17 companies in 2025. Trend: 2023 $1,285 · 2024 $1,751 · 2025 $1,459
Food & beverage: $1,285Education: $175
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 5 | $160 |
| LEO Pharma Inc. | 3 | $149 |
| Janssen Biotech, Inc. | 4 | $143 |
| GENZYME CORPORATION | 4 | $123 |
| UCB, Inc. | 4 | $123 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $111 |
| Regeneron Healthcare Solutions, Inc. | 4 | $92 |
| Galderma Laboratories, L.P. | 5 | $90 |
| ABBVIE INC. | 4 | $87 |
| Lilly USA, LLC | 4 | $77 |
Products named: DUPIXENT, TREMFYA, Bimzelx, COSENTYX, ANZUPGO, NEMLUVIO, TALTZ, CIBINQO.
Industry payments across CO — which companies pay providers there.
